Skip to content
Biotech For FIRE
  • Biotech
  • Holorogy
  • Investing
  • Book Review
  • News
  • About Me
  • Subscribe
  • Contact

biosimilar

  • Home
  • biosimilar

How to think about biosimilar humira for ABBV and AMGN stock investing – $ABBV $AMGN

Posted by By biotechwarrior November 5, 2022Posted inInvesting Thoughts, Talking about BiotechNo Comments
2023 is a special year in pharmaceutical industry - we will see what happens when the biggest product in pharmaceutical industry - HUMIRA - faces biosimilar competition. As you all…
Read More

Drugs with structural defense against biosimilar/generic competition: #1 Krystexxa

Posted by By biotechwarrior January 30, 2022Posted inTalking about BiotechNo Comments
As an investor, you are always looking for a company with sustainable moat - a moat that can be preserved over time and a moat that can become stronger over…
Read More
Recent posts
  • Pharma update: Bullish for 4Q24
  • Immunology market update (positive: $ABBV $UCB / negative: $JNJ, $NVS, $LLY, $BMY, $AMGN)
  • REGN’s CRL and its impact on wet AMD market: 2H23 Biotech/Pharma outlook
  • 2H23 Pharma/Biotech Outlook (Part. 1)
  • $RPRX: Curious case of insider activities at Royalty Pharma (CEO buying, but everyone else is selling)

Loading
Follow Us
  • X
About Me
Logo
Former Biotech hedge fund analyst turned internet writer. Biotech can be fun and help with our FIRE plan. Still got a long way to go and wanted to share my journey. I am a Baker Brother wannabe. You can reach me at biotechwarrior@biotechforfire.tech
Subscribe for the latest posts

Loading
Useful Links
  • Endpoints News
  • FiercePharma
  • FierceBiotech
Copyright 2026 — Biotech For FIRE. All rights reserved. Sinatra WordPress Theme
Scroll to Top